A French lawmaker is urging the country’s market regulator to reconsider its “incomprehensible” decision last month to OK the cryptocurrency exchange Binance.
As the Financial Times reported Monday (June 27), Aurore Lalucq, French MEP and member of the European parliament’s Committee on Economic and Monetary Affairs, wants the Autorité des Marchés Financiers (AMF) to review its ruling, which she said gave Binance a “guarantee of respectability.”
The report noted that Lalucq’s comments are part of a larger wave of concern about the AMF’s decision in May to register one of Binance’s subsidiaries as a digital assets services company.
While Binance received a warm welcome in France, the trading platform hasn’t been as lucky in other countries.
As PYMNTS reported, the company has been investigated in the U.S. by a host of federal agencies, including the IRS, Department of Justice and the Securities and Exchange Commission.
And last June, the Financial Conduct Authority in the U.K. said Binance was “not capable of being effectively supervised,” warning that its “complex and high-risk financial products” posed “a significant risk to consumers.”
More recently, the FCA said it was concerned about possible risk to consumers stemming from a deal giving Binance access to U.K. payments network Paysafe.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan